US Archives - Page 92 of 185 - European Medical Journal

IL-23 Inhibitor Resolves Severe Psoriasis Triggered by Adalimumab

In a compelling case that underscores the complexity of biologic therapies, a patient with hidradenitis suppurativa (HS) developed adalimumab-induced pustular psoriasis, which was successfully treated with guselkumab.

New Combo Therapy Delays HER2+ Breast Cancer: ASCO 2025

Trastuzumab deruxtecan combined with pertuzumab significantly delayed disease progression compared to standard care in patients with HER2-positive advanced breast cancer, according to initial findings from the DESTINY-Breast09 Phase III trial.

Breast Cancer Survivors Show Unexpected Lower Alzheimer’s Risk

Breast cancer survivors may face a lower risk of Alzheimer’s disease than their cancer-free peers, according to a large retrospective cohort study examining long-term cognitive outcomes following treatment.

Digital Inhalers Signal Impending COPD Attacks

Digital inhaler metrics may offer an early signal of impending COPD exacerbations, according to a new pilot study evaluating real-world use of the ProAir Digihaler among high-risk patients.

New Strategies Emerge for TB-Related Drug Reactions

A personalized approach to managing tuberculosis drug reaction with eosinophilia and systemic symptoms, or TB DRESS, is gaining momentum as clinicians face increasing challenges in treating tuberculosis in immunocompromised populations, particularly people living with HIV.

New Insight: Balance Dysfunction in Sjogren’s Syndrome

Vestibular dysfunction and impaired balance may be more common in patients with primary Sjogren’s syndrome than previously understood, according to new research exploring the condition’s neurological impact.

Improving Latent Tuberculosis Screening Prior to Immunosuppression

A new study in Calgary hospitals highlights the need to optimise latent tuberculosis testing prior to patient hospitalisation and…

Dupilumab Flagged for Higher Lymphoma Risk in Asthma

A population-based cohort study finds that asthma patients treated with dupilumab may face an increased risk of developing lymphoma, particularly T and natural killer (NK) cell subtypes, compared to those treated with standard combination inhalers.

Pro-Inflammatory Diets Linked to Higher Mortality in Colon Cancer: ASCO 2025

Pro-inflammatory diets may increase the risk of death in patients with Stage III colon cancer, according to a new analysis of dietary patterns in a large cohort of U.S. patients.

New Migraine Treatment Blends Telehealth Approaches

An emerging treatment model for migraine integrates behavioral and pharmacologic approaches via telehealth, potentially improving access and outcomes for patients with this highly disabling neurological condition.